Ingenol Mebutate is a diterpene ester pharmaceutical compound that was developed as a topical treatment for actinic keratosis, a precancerous skin condition associated with chronic ultraviolet exposure.
It acts locally on abnormal keratinocytes and produces a rapid pharmacological response involving protein kinase C activation, cellular apoptosis and inflammatory mechanisms.
Ingenol Mebutate is a specialized pharmaceutical compound requiring controlled synthesis, purification and analytical characterization. Its quality evaluation may include identity, assay, related substances, residual solvents, water content, elemental impurities and stability-related degradation products.
Because Ingenol Mebutate is a potent dermatological active ingredient, appropriate controls for handling, manufacturing and analytical testing are important.
CAS Number: 75526-95-7
Molecular Formula: C25H34O6
Molecular Weight: 430.54 g/mol
Chemical Name: Ingenol Mebutate
Drug Class: Dermatological Agent
Pharmacological Class: Diterpene Ester
Therapeutic Class: Topical Antineoplastic / Dermatological Agent
Therapeutic Area: Dermatology
Ingenol Mebutate produces a rapid local response through activation of protein kinase C (PKC) and other cellular signaling pathways.
Its pharmacological effects include:
These effects contribute to the elimination of abnormal keratinocytes associated with actinic keratosis.
Ingenol Mebutate was developed for topical treatment of:
Regulatory status should be considered when describing current commercial use, as the regulatory availability of ingenol mebutate-containing products has changed in various markets.
Actinic keratosis develops following cumulative ultraviolet exposure and can appear as rough, scaly lesions on sun-exposed skin.
Ingenol Mebutate was developed as a short-duration topical therapy designed to act directly at the site of the lesion.
Ingenol Mebutate is a naturally derived diterpene ester related to ingenol. It contains multiple oxygenated functional groups and a hydrophobic diterpene framework.
The compound is generally handled as a specialized pharmaceutical solid and requires appropriate protection from unsuitable environmental conditions during storage.
Ingenol Mebutate API quality evaluation may include:
Ingenol Mebutate should be stored in a tightly closed container under controlled pharmaceutical conditions and protected from excessive heat, moisture and direct light. Final storage conditions should follow validated stability data.
Ingenol Mebutate is relevant to research involving:
Ingenol Mebutate is a diterpene ester dermatological compound with CAS Number 75526-95-7, molecular formula C25H34O6, and molecular weight 430.54 g/mol. It was developed as a topical treatment for actinic keratosis and produces its effects through PKC activation, cellular apoptosis and local inflammatory responses.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.5% |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 2.0% |
| Water Content | NMT 2.0% |